Last reviewed · How we verify
NCT04609839: TeleRea'nCo
FOLLOW-UP OF PATIENTS WITH COVID-19.
trial testing Follow-up of patients with COVID-19 in Patient Admitted to Intensive Care Unit for COVID-19. Withdrawn.
17 October 2023
Quick facts
| Lead sponsor | University Hospital, Strasbourg, France |
|---|---|
| Status | Withdrawn |
| Study type | OBSERVATIONAL |
| Start date | 15 September 2020 |
| Primary completion | 17 October 2023 |
| Estimated completion | 17 October 2023 |
| Sites | 1 location across France |
Drugs / interventions tested
- Follow-up of patients with COVID-19
Conditions studied
- Patient Admitted to Intensive Care Unit for COVID-19 — all drugs for Patient Admitted to Intensive Care Unit for COVID-19 →
Sponsor
University Hospital, Strasbourg, France
Who can join
18 and older, any sex, with Patient Admitted to Intensive Care Unit for COVID-19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Some patients admitted to intensive care for a severe form of COVID-19 could have respiratory, cardiac, renal and neurological sequelae in the medium or long term. The results of this research will allow an improvement in the understanding and management of patients in the medium and long term.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Post-acute COVID-19 syndrome and kidney diseases: what do we know?
Copur S, Berkkan M, Basile C, Tuttle K, et al · · 2022 · cited 39× · PMID 35294747 · DOI 10.1007/s40620-022-01296-y
Verify or expand the search:
- PubMed search for NCT04609839
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Hospital, Strasbourg, France trials
Trials by the same sponsor.
- NCT07418554 — Sleep Disturbances in Children and Adolescents With Post-traumatic Stress Disorder (PTSD): a Randomized Double-blind Pla · Phase 3 · not yet recruiting
- NCT07108582 — Reducing Chronic Pain After Lung Surgery: A Trial of Limiting NSAIDs During Recovery · Phase 3 · not yet recruiting
- NCT07302646 — Optimizing Reduced-Flow, Low-Volume Contrast Protocols for Cerebral Angiography in Unruptured Aneurysms · NA · not yet recruiting
- NCT07273968 — Clinical Study Evaluating the Effect of Virtual Reality on Reducing Patients' Anxiety During Wisdom Teeth Extraction · NA · not yet recruiting
- NCT07214103 — Phase IIb Multicenter Randomized Controlled Trial Evaluating the Efficacy of Sivelestat in Patients With Septic Coagulop · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04609839 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Strasbourg, France
- Last refreshed: 16 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04609839.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing